BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37777411)

  • 41. Synergistic relationship between dipeptidyl peptidase IV and neutral endopeptidase expression and the combined prognostic significance in osteosarcoma patients.
    Zhang H; Lin H; Mo X; Chen G; Lin L
    Med Oncol; 2013; 30(3):608. PubMed ID: 23686701
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CBX3 predicts an unfavorable prognosis and promotes tumorigenesis in osteosarcoma.
    Ma C; Nie XG; Wang YL; Liu XH; Liang X; Zhou QL; Wu DP
    Mol Med Rep; 2019 May; 19(5):4205-4212. PubMed ID: 30942427
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Osteosarcoma and other tumors of bone.
    Mertens WC; Bramwell V
    Curr Opin Oncol; 1995 Jul; 7(4):349-54. PubMed ID: 7578383
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of Prognostic RBPs in Osteosarcoma.
    Li B; Fang L; Wang B; Yang Z; Zhao T
    Technol Cancer Res Treat; 2021; 20():15330338211004918. PubMed ID: 33754909
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Associations of polymorphisms in the bone morphogenetic protein-2 gene with risk and prognosis of osteosarcoma in a Chinese population.
    Cong Y; Li CJ; Zhao JN; Liu XZ; Shi X
    Tumour Biol; 2015 Mar; 36(3):2059-64. PubMed ID: 25391427
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [HLA phenotype in patients with osteosarcoma].
    Shimizu T
    Nihon Seikeigeka Gakkai Zasshi; 1989 Apr; 63(4):269-73. PubMed ID: 2738427
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MicroRNA-9 expression is a prognostic biomarker in patients with osteosarcoma.
    Xu SH; Yang YL; Han SM; Wu ZH
    World J Surg Oncol; 2014 Jun; 12():195. PubMed ID: 24969351
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Four-Pseudogene Classifier Identified by Machine Learning Serves as a Novel Prognostic Marker for Survival of Osteosarcoma.
    Liu F; Xing L; Zhang X; Zhang X
    Genes (Basel); 2019 May; 10(6):. PubMed ID: 31146489
    [TBL] [Abstract][Full Text] [Related]  

  • 49. WNT6 is an effective marker for osteosarcoma diagnosis and prognosis.
    Jiang K; Li S; Li L; Wang X; Gu Y; Jin Z
    Medicine (Baltimore); 2018 Nov; 97(46):e13011. PubMed ID: 30431574
    [TBL] [Abstract][Full Text] [Related]  

  • 50. miR-21 predicts poor prognosis in patients with osteosarcoma.
    Ren X; Shen Y; Zheng S; Liu J; Jiang X
    Br J Biomed Sci; 2016 Oct; 73(4):158-162. PubMed ID: 27922432
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PLOD1 Is a Prognostic Biomarker and Mediator of Proliferation and Invasion in Osteosarcoma.
    Jiang H; Guo W; Yuan S; Song L
    Biomed Res Int; 2020; 2020():3418398. PubMed ID: 33134376
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Questions about XY Wen et al. entitled "Matrix metalloproteinase 2 expression and survival of patients with osteosarcoma: a meta-analysis".
    Liu F; Zhang Q
    Tumour Biol; 2015 Feb; 36(2):557-8. PubMed ID: 25663465
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HER-2 expression in biopsy and surgical specimen on prognosis of osteosarcoma: A systematic review and meta-analysis of 16 studies.
    Zhang Q; Liu F; Wang B; Li Z; Zhou D; Yang Q; Dong J; Li J
    Medicine (Baltimore); 2016 Jun; 95(23):e3661. PubMed ID: 27281068
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IRX1 hypomethylation in osteosarcoma metastasis.
    Lu J; Wang J
    Oncotarget; 2015 Jul; 6(19):16802-3. PubMed ID: 26158902
    [No Abstract]   [Full Text] [Related]  

  • 55. Identification of the Novel Target Genes for Osteosarcoma Therapy Based on Comprehensive Bioinformatic Analysis.
    Zhou X; Fan Y; Ye W; Jia B; Yang Y; Liu Y
    DNA Cell Biol; 2020 Jul; 39(7):1172-1180. PubMed ID: 32584170
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Molecular characterization of osteosarcomas].
    Baumhoer D
    Pathologe; 2013 Nov; 34 Suppl 2():260-3. PubMed ID: 24196625
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glucocorticoid receptor DNA binding factor 1 expression and osteosarcoma prognosis.
    Zhao J; Xu H; He M; Wu Y
    Tumour Biol; 2014 Dec; 35(12):12449-58. PubMed ID: 25185653
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Unlocking the potential of molecular-driven stratification for osteosarcoma treatment and prognosis.
    Moquin-Beaudry G; da Costa MEM; Gaspar N; Marchais A
    Oncotarget; 2023 Feb; 14():132. PubMed ID: 36780321
    [No Abstract]   [Full Text] [Related]  

  • 59. A risk score model based on endoplasmic reticulum stress related genes for predicting prognostic value of osteosarcoma.
    Zhao Y; Gao J; Fan Y; Xu H; Wang Y; Yao P
    BMC Musculoskelet Disord; 2023 Jun; 24(1):519. PubMed ID: 37353812
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of 6 gene markers for survival prediction in osteosarcoma cases based on multi-omics analysis.
    Li R; Wang G; Wu Z; Lu H; Li G; Sun Q; Cai M
    Exp Biol Med (Maywood); 2021 Jul; 246(13):1512-1523. PubMed ID: 33563042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.